EVI1-a novel oncogene in prostate carcinoma

被引：0

作者：

Wang, H. ^{[1
,2
]}

Queisser, A. ^{[3
]}

Hagedorn, S. ^{[3
]}

Konantz, M. ^{[1
]}

Schaefer, T. ^{[1
]}

Alavi, S. ^{[3
]}

Vogel, W. ^{[4
,5
]}

Maessenhausen, A., V ^{[3
]}

Kristiansen, G. ^{[3
]}

Duensing, S. ^{[6
]}

Kirfel, J. ^{[3
]}

Perner, S. ^{[4
,5
]}

Lengerke, C. ^{[1
,2
,7
]}

机构：

[1] Univ Basel Hosp, Dept Biomed, Basel, Switzerland

[2] Univ Tubingen, Med Ctr 2, Dept Hematol & Oncol, Tubingen, Germany

[3] Univ Hosp Bonn, Sect Prostate Canc Res, Inst Pathol, Ctr Integrated Oncol Cologne Bonn, Bonn, Germany

[4] Univ Hosp Luebeck, Pathol, Lubeck, Germany

[5] Leibniz Res Ctr Borstel, Borstel, Germany

[6] Heidelberg Univ, Sch Med, Sect Mol Urooncol, Dept Urol, Heidelberg, Germany

[7] Univ Basel Hosp, Clin Hematol, Basel, Switzerland

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P884

引用

页码：267 / 267

页数：1

共 50 条

[31] The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL
Vasyutina, E.
Boucas, J. M.
Bloehdorn, J.
Aszyk, C.
Crispatzu, G.
Stiefelhagen, M.
Breuer, A.
Mayer, P.
Lengerke, C.
Doehner, H.
Beutner, D.
Rosenwald, A.
Stilgenbauer, S.
Hallek, M.
Benner, A.
Herling, M.
LEUKEMIA, 2015, 29 (10) : 2003 - 2014
[32] EVI-1 oncogene expression predicts survival in chronic phase CML patients resistant to imatinib
Milojkovic, D.
De Melo, V. A.
Gerrard, G.
Goldman, J. M.
Apperley, J. F.
Foroni, L.
Reid, A. G.
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 22 - 23
[33] EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Tingting Cai
Jieqi Zhou
Yuanyuan Zeng
Wenwen Du
Yang Zhang
Ting Liu
Yulong Fu
Jian-an Huang
Qian Qian
Jianjie Zhu
Chunhua Ling
Zeyi Liu
Journal of Experimental & Clinical Cancer Research, 39
[34] Transcription factor LSF is a novel oncogene for hepatocellular carcinoma (HCC)
Yoo, Byoung Kwon
Emdad, Luni
Gredler, Rachel
Chen, Dong
Su, Zhao-zhong
Fisher, Paul B.
Sarkar, Devanand
CANCER RESEARCH, 2010, 70
[35] ACTL6A is a novel oncogene and prognostic biomarker for prostate cancer
Chuu, Chih-Pin
Lin, Ching-Yu
Huang, Shih-Han
Tsai, Kelvin K-C
ANNALS OF ONCOLOGY, 2019, 30
[36] EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Cai, Tingting
Zhou, Jieqi
Zeng, Yuanyuan
Du, Wenwen
Zhang, Yang
Liu, Ting
Fu, Yulong
Huang, Jian-an
Qian, Qian
Zhu, Jianjie
Ling, Chunhua
Liu, Zeyi
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
[37] EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Cai, Tingting
Zhou, Jieqi
Zhang, Yang
Zeng, Yuanyuan
Du, Wenwen
Liu, Ting
Fu, Yulong
Huang, Jian-An
Zhu, Jianjie
Ling, Chunhua
Liu, Zeyi
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[38] Regulation of the leukemia associated oncogene and developmental regulator EVI1 by all-trans retinoic acid
Bingemann, S.
Wieser, R.
FEBS JOURNAL, 2008, 275 : 135 - 135
[39] The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops
Ottema, Sophie
Mulet-Lazaro, Roger
Erpelinck-Verschueren, Claudia
van Herk, Stanley
Havermans, Marije
Varea, Andrea Arricibita
Vermeulen, Michael
Beverloo, H. Berna
Groeschel, Stefan
Haferlach, Torsten
Haferlach, Claudia
Wouters, Bas J.
Bindels, Eric
Smeenk, Leonie
Delwel, Ruud
NATURE COMMUNICATIONS, 2021, 12 (01)
[40] The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops
Sophie Ottema
Roger Mulet-Lazaro
Claudia Erpelinck-Verschueren
Stanley van Herk
Marije Havermans
Andrea Arricibita Varea
Michael Vermeulen
H. Berna Beverloo
Stefan Gröschel
Torsten Haferlach
Claudia Haferlach
Bas J. Wouters
Eric Bindels
Leonie Smeenk
Ruud Delwel
Nature Communications, 12

← 1 2 3 4 5 →